What is the expected growth forecast for the Platelet aggregation reagents market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Platelet aggregation reagents market?

Increasing demand for diagnostic tests and rising awareness of blood disorders drive the market.

What are the major challenges facing the Platelet aggregation reagents market?

High costs and limited accessibility in developing regions hinder market growth.

Which regions are the leaders in the Platelet aggregation reagents market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the Platelet aggregation reagents market?

Leading companies include Roche, Siemens, and Abbott, offering a range of diagnostic products.

What are the future opportunities in the Platelet aggregation reagents market?

Emerging markets and innovative technologies offer growth opportunities for the future outlook.

How does technology impact the Platelet aggregation reagents market?

Advances in automation and point-of-care testing improve diagnostic efficiency and accuracy.

What is the regulatory landscape like for the Platelet aggregation reagents market?

Stringent regulations and standards ensure product safety and efficacy.

What does the future outlook hold for the Platelet aggregation reagents market size?

The market is expected to reach USD 2.5 billion by 2033, driven by increasing demand.

Platelet aggregation reagents Value Chain Analysis & Forecast Outlook 2033

Platelet aggregation reagents by Application (Experiment, Medical, Others), by Types (ADP, Acetylsalicylic Acid, Prostaglandin, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Platelet aggregation reagents Market Size | CAGR 7.2 Forecast 2033

Platelet aggregation reagents Value Chain Analysis & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Platelet aggregation reagents Market Overview

The Platelet aggregation reagents market is a crucial segment of the in vitro diagnostics industry, playing a vital role in the diagnosis and monitoring of platelet-related disorders. As the global healthcare landscape continues to evolve, the Platelet aggregation reagents market size is poised for significant growth, with a promising growth outlook and market forecast that underscores the industry's expansion potential. The scope of this market encompasses a range of products, including platelet aggregometers, reagents, and consumables, which are used in various applications, such as research, clinical diagnostics, and quality control.

Loading chart…

The current Platelet aggregation reagents market size is approximately $540 million, with a growth forecast that indicates a compound annual growth rate (CAGR) of 8.5% during the forecast period from 2026 to 2033. Key forces shaping the industry include technology shifts, such as the adoption of point-of-care testing, regulations, like the increasing demand for quality control, and consumer behavior, driven by the growing awareness of platelet-related disorders. The largest region in the Platelet aggregation reagents market is North America, while the fastest-growing region is Asia-Pacific, driven by the expanding healthcare infrastructure and research activities in countries like China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BioMed; Chrono-log Corporation; Alpha Laboratorie; Mascia Brunelli; Biolife Italiana; Haemochrom Diagnostica; hartbio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Platelet aggregation reagents market is poised for significant growth, driven by increasing demand for diagnostic and research applications. The Platelet aggregation reagents market size is expected to expand rapidly, with a substantial growth forecast.

Growth Drivers2 items

Advances in technology have led to the development of more sensitive and specific Platelet aggregation reagents, enabling accurate diagnosis and monitoring of platelet-related disorders, which is expected to drive the Platelet aggregation reagents market size.

The increasing prevalence of cardiovascular diseases and bleeding disorders has created a high demand for Platelet aggregation reagents, contributing to the growth forecast of the Platelet aggregation reagents market.

Restraints2 items

Stringent regulatory requirements and high development costs associated with Platelet aggregation reagents may hinder the growth of the Platelet aggregation reagents market.

The availability of alternative diagnostic methods may also limit the adoption of Platelet aggregation reagents, affecting the Platelet aggregation reagents market size.

Opportunities2 items

Emerging economies present significant opportunities for the Platelet aggregation reagents market, driven by increasing healthcare expenditure and growing demand for diagnostic services, which is expected to drive the growth forecast.

The development of novel Platelet aggregation reagents with improved sensitivity and specificity is expected to create new opportunities for market players, contributing to the Platelet aggregation reagents market size.

Challenges2 items

Market players in the Platelet aggregation reagents market face significant challenges in terms of competition, pricing, and supply chain management, which may impact the Platelet aggregation reagents market size.

The need for ongoing investment in research and development to stay ahead of the competition and address evolving customer needs is a significant challenge in the Platelet aggregation reagents market, affecting the growth forecast.

Market Segmentation

Loading chart…

The Application segment of the Platelet aggregation reagents market refers to the various uses of these reagents in different fields. This segment is crucial in understanding the Platelet aggregation reagents segmentation as it highlights the diverse applications of these reagents, contributing to the overall market size. The application segment can be further divided into research institutions, hospitals, and diagnostic laboratories, among others.

The Types segment of the Platelet aggregation reagents market is categorized into different subtypes, including [object Object] and [object Object]. This segmentation is vital in market taxonomy as it provides insights into the various types of reagents available, their characteristics, and their contributions to the overall market size. Understanding the types of Platelet aggregation reagents is essential for manufacturers and consumers to make informed decisions about their production and use.

Platelet aggregation reagents Segmentation Breakdown9 items

Application

Experiment

Medical

Others

Types

ADP

Acetylsalicylic Acid

Prostaglandin

Others

Regional Insights

Loading chart…

The Platelet aggregation reagents market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. Europe's growth is driven by policies supporting research and development, a strong ecosystem, and significant investments in medical research. Asia Pacific's growth is fueled by increasing adoption of medical technologies, large demographics, and improving infrastructure. Latin America's growth is driven by growing adoption and increasing investments, while the Middle East & Africa region is driven by improving infrastructure and increasing adoption.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by the aforementioned factors. As the Platelet aggregation reagents market continues to evolve, understanding the regional dynamics and key drivers will be crucial for stakeholders to make informed decisions and capitalize on emerging opportunities.

Competitive Landscape

The Platelet aggregation reagents market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Platelet aggregation reagents competitive landscape is characterized by high competition, with companies focusing on differentiation through innovative products and services. Pricing strategies also play a crucial role, with companies seeking to balance revenue goals with affordability for end-users.

Companies in the market employ various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To address these challenges, companies are focusing on strategic initiatives such as regional expansion, innovation, and premium pricing.

BioMed: regional expansion

Chrono-log Corporation: innovation pipeline

Alpha Laboratorie: premium pricing

Mascia Brunelli: local manufacturing

Biolife Italiana: OEM tie-ups

Haemochrom Diagnostica: vertical integration

Key Platelet aggregation reagents Companies7 items

BioMed

Chrono-log Corporation

Alpha Laboratorie

Mascia Brunelli

Biolife Italiana

Haemochrom Diagnostica

hartbio

Market Ecosystem

The Platelet aggregation reagents ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of platelet aggregation reagents, which are used to diagnose and monitor blood clotting disorders. The ecosystem is interconnected, with each participant relying on others to deliver high-quality products and services.

Raw material suppliers — providing biochemical components

OEMs/manufacturers — producing platelet aggregation reagents

Technology providers — developing testing platforms and software

Distributors/channel partners — delivering products to end users

Service providers/after-sales — offering technical support and maintenance

End users/buyers — utilizing platelet aggregation reagents in research and diagnostics

Regulators/standards bodies — establishing guidelines and approvals

In the Platelet aggregation reagents ecosystem, control points are influenced by regulators and standards bodies, who set guidelines and approvals for product development and distribution. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact the supply chain. Switching costs and partnerships are also crucial, as end users often rely on specific products and services, and may face significant costs when changing suppliers. Furthermore, the ecosystem differs by region, with varying regulatory requirements and market demands. A thorough value chain analysis is necessary to understand these complexities and identify opportunities for growth and innovation.

Recent Industry Insights

The Platelet aggregation reagents industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between major pharmaceutical companies and research institutions, have driven innovation in the field. Notable mergers and acquisitions have also taken place, leading to the expansion of product portfolios and increased market share. Furthermore, several companies have launched new products and technologies, enhancing the accuracy and efficiency of platelet aggregation testing.

Additionally, regulatory changes have influenced the Platelet aggregation reagents industry trends, with a growing emphasis on standardization and quality control. Shifts in consumer and enterprise trends have also been observed, with a rising demand for point-of-care testing and personalized medicine. Funding rounds and expansions have supported the growth of start-ups and small businesses, contributing to the development of novel platelet aggregation reagents and technologies.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Platelet aggregation reagents market outlook. The market attractiveness is moderate, driven by increasing demand for diagnostic tests in the healthcare sector. The competitive intensity is high, with key players investing in research and development to improve product offerings. The long-term outlook is positive, with growing applications in medical research and clinical diagnostics.

The innovation landscape is rapidly evolving, with advancements in technology and new product launches. The demand–supply balance is expected to be stable, with key players maintaining their market share. However, key risk factors such as regulatory changes and intense competition may impact market growth. Overall, the Platelet aggregation reagents market is expected to experience steady growth, driven by increasing demand and innovative product offerings.

11 items

1. Executive Summary

2. Platelet aggregation reagents Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Platelet aggregation reagents Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Platelet aggregation reagents Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Experiment

6.1.2. Medical

6.1.3. Others

6.2. Global Platelet aggregation reagents Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. ADP

6.2.2. Acetylsalicylic Acid

6.2.3. Prostaglandin

6.2.4. Others

6.3. Global Platelet aggregation reagents Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Platelet aggregation reagents Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Platelet aggregation reagents Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Platelet aggregation reagents Market Competition by Key Manufacturers

8.1. Global Platelet aggregation reagents Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Platelet aggregation reagents: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BioMed

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Chrono-log Corporation

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Alpha Laboratorie

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Mascia Brunelli

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Biolife Italiana

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Haemochrom Diagnostica

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. hartbio

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Platelet aggregation reagents Market

Figure 4: Global Platelet aggregation reagents Market: Drivers

Figure 5: Global Platelet aggregation reagents Market: Challenges

Figure 6: Global Platelet aggregation reagents Market: Trends

Figure 7: Global Platelet aggregation reagents Market: Opportunity

Figure 8: Global Platelet aggregation reagents Market: Restraint

Figure 9: Global Platelet aggregation reagents Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Platelet aggregation reagents Market Value (USD Million) By Region

Figure 15: Global Platelet aggregation reagents Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Platelet aggregation reagents Market Value (USD Million) By Region

Figure 23: Global Platelet aggregation reagents Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Platelet aggregation reagents Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Platelet aggregation reagents Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Platelet aggregation reagents Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Platelet aggregation reagents Market Value (USD Million) By Region

Table 10: Global Platelet aggregation reagents Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Platelet aggregation reagents Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Platelet aggregation reagents Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Platelet aggregation reagents Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BioMed Basic Information And Sales Area

Table 31: BioMed. Products Portfolio

Table 32: Chrono-log Corporation Basic Information And Sales Area

Table 33: Chrono-log Corporation. Products Portfolio

Table 34: Alpha Laboratorie Basic Information And Sales Area

Table 35: Alpha Laboratorie. Products Portfolio

Table 36: Mascia Brunelli Basic Information And Sales Area

Table 37: Mascia Brunelli. Products Portfolio

Table 38: Biolife Italiana Basic Information And Sales Area

Table 39: Biolife Italiana. Products Portfolio

Table 40: Haemochrom Diagnostica Basic Information And Sales Area

Table 41: Haemochrom Diagnostica. Products Portfolio

Table 42: hartbio Basic Information And Sales Area

Table 43: hartbio. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global Platelet aggregation reagents Market Value (USD Million) By Region

Table 49: Global Platelet aggregation reagents Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Platelet aggregation reagents Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BioMed; Chrono-log Corporation; Alpha Laboratorie; Mascia Brunelli; Biolife Italiana; Haemochrom Diagnostica; hartbio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options